Spectranetics Corporation has appointed Michael J. Voss as vice president and general manager of Vascular Intervention (VI). Mr. Voss has over 15 years of experience in the medical device business with a broad sales and marketing background. Prior to joining Spectranetics, he was the Global Vice President of Marketing for Bard Access Systems at CR Bard, where he was responsible for planning, brand building, sales promotions and pricing for a division with annual revenues in excess of $500 million. Prior to CR Bard, he was at Cordis, a Johnson & Johnson company, in several positions including division sales manager and director of marketing for coronary stents. Mr. Voss started his medical device career at Boston Scientific Corporation where he served in a variety of roles including global marketing manager, product manager, business unit manager, and manufacturing manager. He also served six years in the United States Army, where he earned the rank of Captain. His responsibilities at Spectranetics will include sales, sales training, marketing, and overall strategy development for the VI business, which includes atherectomy devices, support catheters and thrombectomy and chronic total occlusion products recently acquired from Kensey Nash Corporation.